Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 27-Feb-24 7:22 PM View:  | Cannon Kara Chief Executive Officer Director | Enzo Biochem Inc. (ENZ) | 23-Feb-24 | Grant | 150,000 | -- | -- | 43% 346.36K to 496.36K | |
| 27-Feb-24 7:22 PM View: | Cannon Kara Chief Executive Officer Director | Enzo Biochem Inc. (ENZ) | 21-Feb-24 | Payment of Exercise | 5,823 | -- | -- | (2%) 352.19K to 346.36K | |
| 27-Feb-24 7:22 PM View: | Cannon Kara Chief Executive Officer Director | Enzo Biochem Inc. (ENZ) | 21-Feb-24 | Option Exercise | 10,640 | -- | -- | 3% 341.55K to 352.19K | |
| 02-Feb-24 9:00 PM View: | Radoff Bradley Louis Director | Enzo Biochem Inc. (ENZ) | 31-Jan-24 | Grant | 79,365 | -- | -- | 2% 4.74M to 4.82M | |
| 02-Feb-24 9:01 PM View: | Tagliaferri Mary Director | Enzo Biochem Inc. (ENZ) | 31-Jan-24 | Grant | 79,365 | -- | -- | 34% 233.02K to 312.38K | |
| 02-Feb-24 9:02 PM View: | Pully Steven J Director | Enzo Biochem Inc. (ENZ) | 31-Jan-24 | Grant | 79,365 | -- | -- | 448% 17.73K to 97.09K | |
| 15-Dec-23 4:01 PM View: | Pully Steven J Director | Enzo Biochem Inc. (ENZ) | 30-Oct-23 | Grant | 17,730 | -- | -- | 100% 0 to 17.73K | |
| 05-Sep-23 9:35 PM View: | Cannon Kara Chief Operating Officer | Enzo Biochem Inc. (ENZ) | 31-Aug-23 | Grant | 345,080 | -- | -- | 715% 48.26K to 393.34K | |
| 05-Sep-23 9:35 PM View: | Cannon Kara Chief Operating Officer | Enzo Biochem Inc. (ENZ) | 31-Aug-23 | Payment of Exercise | 63,700 | $1.54 | $98,098.00 | (16%) 393.34K to 329.64K | |
| 13-Feb-23 9:41 PM View: | Wolf James G. | Enzo Biochem Inc. (ENZ) | 13-Feb-23 | Purchase | 5,000 | $1.29 | $6,450.00 | < 1% 4.52M to 4.52M | |
| 13-Feb-23 9:40 PM View: | Walters Ian B. Director | Enzo Biochem Inc. (ENZ) | 13-Feb-23 | Grant | 75,188 | -- | -- | 93% 80.73K to 155.92K | |
| 13-Feb-23 9:41 PM View: | Wolf James G. | Enzo Biochem Inc. (ENZ) | 13-Feb-23 | Purchase | 5,000 | $1.28 | $6,425.00 | < 1% 4.51M to 4.52M | |
| 13-Feb-23 9:41 PM View: | Wolf James G. | Enzo Biochem Inc. (ENZ) | 10-Feb-23 | Private Purchase | 5,000 | $1.29 | $6,450.00 | < 1% 4.51M to 4.51M | |
| 13-Feb-23 9:39 PM View: | Tagliaferri Mary Director | Enzo Biochem Inc. (ENZ) | 09-Feb-23 | Grant | 75,188 | -- | -- | 93% 80.73K to 155.92K | |
| 13-Feb-23 9:38 PM View: | Radoff Bradley Louis Director | Enzo Biochem Inc. (ENZ) | 09-Feb-23 | Grant | 75,188 | -- | -- | 2% 4.24M to 4.31M | |
| 30-Jan-23 12:01 PM View: | Wolf James G. 10% Owner | Enzo Biochem Inc. (ENZ) | 27-Jan-23 | Private Purchase | 11,800 | $1.40 | $16,520.00 | < 1% 4.5M to 4.51M | |
| 23-Jan-23 1:15 PM View: | Wolf James G. 10% Owner | Enzo Biochem Inc. (ENZ) | 23-Jan-23 | Conversion | 263,200 | $2.83 | $744,250.00 | 6% 4.23M to 4.5M | |
| 31-Jan-23 4:01 PM View: | Cannon Kara Chief Operating Officer | Enzo Biochem Inc. (ENZ) | 28-Dec-22 | Grant | 12,600 | -- | -- | 50% 25.11K to 37.71K | |
| 19-Jan-23 2:37 PM View: | Wolf James G. 10% Owner | Enzo Biochem Inc. (ENZ) | 16-Dec-22 | Conversion | 33,700 | $2.50 | $84,250.00 | < 1% 4.6M to 4.63M | |
| 19-Jan-23 2:37 PM View: | Wolf James G. 10% Owner | Enzo Biochem Inc. (ENZ) | 15-Dec-22 | Conversion | 85,100 | $2.50 | $212,750.00 | 2% 4.52M to 4.6M | |
| 19-Jan-23 2:37 PM View: | Wolf James G. 10% Owner | Enzo Biochem Inc. (ENZ) | 14-Dec-22 | Conversion | 136,200 | $2.50 | $340,500.00 | 3% 4.38M to 4.52M | |
| 28-Nov-22 6:27 PM View: | Erfanian Hamid Chief Executive Officer Director | Enzo Biochem Inc. (ENZ) | 23-Nov-22 | Private Purchase | 100,000 | $1.97 | $197,000.00 | 36% 274.6K to 374.6K | |
| 19-Jan-23 2:37 PM View: | Wolf James G. 10% Owner | Enzo Biochem Inc. (ENZ) | 21-Nov-22 | Conversion | 24,700 | $2.50 | $61,750.00 | < 1% 4.35M to 4.38M | |
| 19-Jan-23 2:37 PM View: | Wolf James G. 10% Owner | Enzo Biochem Inc. (ENZ) | 17-Nov-22 | Conversion | 300 | $2.50 | $750.00 | < 1% 4.35M to 4.35M | |
| 19-Jan-23 2:37 PM View: | Wolf James G. 10% Owner | Enzo Biochem Inc. (ENZ) | 01-Nov-22 | Purchase | 8,500 | $2.14 | $18,225.00 | < 1% 4.35M to 4.35M | |
| 19-Jan-23 2:37 PM View: | Wolf James G. 10% Owner | Enzo Biochem Inc. (ENZ) | 31-Oct-22 | Private Purchase | 14,500 | $2.15 | $31,175.00 | < 1% 4.33M to 4.35M | |
| 19-Jul-22 5:30 PM View: | Cannon Kara Chief Operating Officer | Enzo Biochem Inc. (ENZ) | 15-Jul-22 | Private Purchase | 2,500 | $2.42 | $6,050.00 | 11% 22.61K to 25.11K | |
| 14-Jul-22 9:31 PM View: | Radoff Bradley Louis Director | Enzo Biochem Inc. (ENZ) | 12-Jul-22 | Grant | 41,666 | -- | -- | < 1% 4.19M to 4.24M | |
| 14-Jul-22 9:31 PM View: | Walters Ian B. Director | Enzo Biochem Inc. (ENZ) | 12-Jul-22 | Grant | 41,666 | -- | -- | 107% 39.06K to 80.73K | |
| 13-Jul-22 7:00 AM View: | Radoff Bradley Louis Director | Enzo Biochem Inc. (ENZ) | 12-Jul-22 | Private Purchase | 12,500 | $2.27 | $28,375.00 | < 1% 4.61M to 4.62M | |
| 14-Jul-22 9:32 PM View: | Tagliaferri Mary Director | Enzo Biochem Inc. (ENZ) | 12-Jul-22 | Grant | 41,666 | -- | -- | 107% 39.06K to 80.73K | |
| 06-Jul-22 4:30 PM View: | Radoff Bradley Louis Director | Enzo Biochem Inc. (ENZ) | 05-Jul-22 | Private Purchase | 120,000 | $2.20 | $264,000.00 | 3% 4.49M to 4.61M | |
| 16-Jun-22 8:29 PM View: | Radoff Bradley Louis Director | Enzo Biochem Inc. (ENZ) | 16-Jun-22 | Purchase | 75,000 | $2.20 | $165,000.00 | 2% 4.42M to 4.49M | |
| 17-Jun-22 4:31 PM View: | Erfanian Hamid Chief Executive Officer | Enzo Biochem Inc. (ENZ) | 15-Jun-22 | Private Purchase | 4,600 | $2.19 | $10,074.00 | 2% 270.0K to 274.6K | |
| 16-Jun-22 8:29 PM View: | Radoff Bradley Louis Director | Enzo Biochem Inc. (ENZ) | 15-Jun-22 | Private Purchase | 50,000 | $2.21 | $110,500.00 | 1% 4.37M to 4.42M | |
| 15-Jun-22 4:31 PM View: | Bench David Chief Financial Officer | Enzo Biochem Inc. (ENZ) | 14-Jun-22 | Private Purchase | 3,500 | $2.15 | $7,525.00 | 53% 6.64K to 10.14K | |
| 29-Apr-22 4:35 PM View: | Walters Ian B. Director | Enzo Biochem Inc. (ENZ) | 27-Apr-22 | Grant | 39,063 | -- | -- | 100% 0 to 39.06K | |
| 29-Apr-22 4:44 PM View: | Tagliaferri Mary Director | Enzo Biochem Inc. (ENZ) | 27-Apr-22 | Grant | 39,063 | -- | -- | 100% 0 to 39.06K | |
| 29-Apr-22 4:40 PM View: | Radoff Bradley Louis Director | Enzo Biochem Inc. (ENZ) | 27-Apr-22 | Grant | 39,063 | -- | -- | < 1% 4.33M to 4.37M | |
| 14-Apr-22 7:58 PM View: | Bench David Chief Financial Officer | Enzo Biochem Inc. (ENZ) | 14-Apr-22 | Grant | 1,620 | $2.90 | $4,698.00 | 32% 5.02K to 6.64K | |
| 15-Apr-22 10:23 AM View: | Radoff Bradley Louis Director | Enzo Biochem Inc. (ENZ) | 14-Apr-22 | Grant | 30,000 | $2.91 | $87,300.00 | < 1% 4.3M to 4.33M | |
| 14-Apr-22 1:52 PM View: | Erfanian Hamid Chief Executive Officer | Enzo Biochem Inc. (ENZ) | 13-Apr-22 | Grant | 10,000 | $2.90 | $29,000.00 | 4% 260.0K to 270.0K | |
| 14-Apr-22 7:58 PM View: | Bench David Chief Financial Officer | Enzo Biochem Inc. (ENZ) | 13-Apr-22 | Grant | 880 | $2.90 | $2,552.00 | 21% 4.14K to 5.02K | |
| 10-Nov-21 5:20 PM View: | Erfanian Hamid Chief Executive Officer | Enzo Biochem Inc. (ENZ) | 08-Nov-21 | Grant | 260,000 | -- | -- | 100% 0 to 260.0K | |
| 17-Mar-21 5:28 PM View: | Harbert Management Corp 10% Owner | Enzo Biochem Inc. (ENZ) | 16-Mar-21 | Market Sale | 300,000 | $4.65 | $1,393,900.00 | (3%) 11.0M to 10.7M | |
| 17-Mar-21 5:28 PM View: | Harbert Management Corp 10% Owner | Enzo Biochem Inc. (ENZ) | 15-Mar-21 | Private Sale | 144,768 | $4.83 | $698,840.00 | (1%) 11.14M to 11.0M | |
| 13-Jan-21 9:44 PM View: | Weiner Barry W PRESIDENT AND TREASURER | Enzo Biochem Inc. (ENZ) | 11-Jan-21 | Grant | 142,586 | -- | -- | 9% 1.51M to 1.66M | |
| 13-Jan-21 9:40 PM View: | Rabbani Elazar Chief Executive Officer Director | Enzo Biochem Inc. (ENZ) | 11-Jan-21 | Grant | 190,114 | -- | -- | 9% 2.07M to 2.26M | |
| 19-Feb-20 2:45 PM View: | Clemens Peter J Iv 10% Owner | Enzo Biochem Inc. (ENZ) | 18-Feb-20 | Market Purchase | 4,000 | $2.20 | $8,800.00 | 18% 22.0K to 26.0K | |
| 19-Feb-20 2:45 PM View: | Clemens Peter J Iv 10% Owner | Enzo Biochem Inc. (ENZ) | 14-Feb-20 | Market Purchase | 6,000 | $2.21 | $13,260.00 | 38% 16.0K to 22.0K |
